Overcoming pharmacokinetic problems in t
✍
Dr. J. A. Obeso; J. Vaamonde; F. Grandas; M. R. Luquin; M. Rodriguez; G. Lera; J
📂
Article
📅
1989
🏛
John Wiley and Sons
🌐
English
⚖ 1023 KB
Daily fluctuations in movement capacity and dyskinesias are well recognized as the two major complications emerging after chronic levodopa treatment. Progressive loss of efficacy leading to severe disability and immobility is a very rare finding, most often reflecting pathological involvement beyond